These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26019689)

  • 21. Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study.
    Huang SP; Guisinger A; Averell C; Bell CF; Rubin B
    Rheumatol Ther; 2023 Jun; 10(3):551-562. PubMed ID: 36738424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ
    J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus.
    Kabadi S; Yeaw J; Bacani AK; Tafesse E; Bos K; Karkare S; DeKoven M; Vina ER
    Lupus; 2018 Oct; 27(11):1799-1809. PubMed ID: 30068254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization.
    Schwarting A; Friedel H; Garal-Pantaler E; Pignot M; Wang X; Nab H; Desta B; Hammond ER
    Rheumatol Ther; 2021 Mar; 8(1):375-393. PubMed ID: 33544369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health care resource utilization in the management of patients with Arginase 1 Deficiency in the US: a retrospective, observational, claims database study.
    Bin Sawad A; Jackimiec J; Bechter M; Hull M; Yeaw J; Wang Y; Diaz GA
    J Med Econ; 2022; 25(1):848-856. PubMed ID: 35695271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
    Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
    Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.
    McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
    Lupus; 2018 Jul; 27(8):1247-1258. PubMed ID: 29665755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
    Bonafede M; Jing Y; Gdovin Bergeson J; Liffmann D; Makenbaeva D; Graham J; Deitelzweig SB
    Hosp Pract (1995); 2011 Aug; 39(3):16-22. PubMed ID: 21881388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma.
    Bhowmik D; Song X; Intorcia M; Kent ST; Shi N
    J Oncol Pharm Pract; 2019 Jun; 25(4):855-864. PubMed ID: 29661050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.
    Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J
    Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
    Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
    J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
    Amand C; Tong S; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare Utilization and Costs Associated with New-Onset Pain in a Medicare Population.
    Staats PS; Patel K; Gillen EM; Bello T; Epple T; Bilder SM; Wisor D
    Pain Physician; 2022 Dec; 25(9):E1415-E1422. PubMed ID: 36608013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review.
    Lin DH; Murimi-Worstell IB; Kan H; Tierce JC; Wang X; Nab H; Desta B; Hammond ER; Alexander GC
    Lupus; 2022 Jun; 31(7):773-807. PubMed ID: 35467448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.